Pulse Biosciences (PLSE) Capital Expenditures Growth (1y) (2016 - 2025)
Pulse Biosciences (PLSE) Capital Expenditures Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 124.80 Bn | 119.58 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.47 Bn | 43.65 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | - |
| 4 | Medline | 32.67 Bn | 30.44 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.06 Bn | 27.40 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 13.91 Bn | 13.35 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.82 Bn | 13.68 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.13 Bn | 11.07 Bn | 736.59 Mn | 21.73% |
| 10 | Pulse Biosciences | 2.11 Bn | 2.03 Bn | - | 238.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 238.71% |
| Sep 30, 2025 | 1,262.50% |
| Jun 30, 2025 | -112.50% |
| Dec 31, 2024 | -27.91% |
| Sep 30, 2024 | -169.57% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | 4.88% |
| Sep 30, 2023 | -62.90% |
| Jun 30, 2023 | -94.10% |
| Mar 31, 2023 | 44.44% |
| Dec 31, 2022 | 114.86% |
| Sep 30, 2022 | -60.51% |
| Jun 30, 2022 | 185.26% |
| Mar 31, 2022 | -47.06% |
| Dec 31, 2021 | 5.15% |
| Sep 30, 2021 | 153.23% |
| Jun 30, 2021 | 233.80% |
| Mar 31, 2021 | -70.18% |
| Dec 31, 2020 | -686.49% |
| Sep 30, 2020 | -88.37% |